Pharma Anti- Counterfeiting 2012 by Virtue Insight Ltd on 18th October 2012, UK

Essex, United Kingdom, September 21, 2012 --(PR.com)-- Virtue Insight Ltd is pleased to announce “Pharma Anti- Counterfeiting 2012 – Competences to Combat Counterfeits in EU & USA” on 18th October 2012 at Marriott Marble Arch Hotel, London, UK.

Visit: http://www.virtueinsight.com/pharma/Pharma-Anti-Counterfeiting-2012/

This conference will gather government bodies, pharmaceutical companies and solution and technology providers to discuss the in-depth insights into the strategies and cutting edge technologies for pharmaceutical anti-counterfeiting. For more info write to info.uk@virtueinsight.com

Or Call at +44 2033024659

Key Themes Discussed at This Conference:-
· Anti-Counterfeiting and Product Security in EU and USA: government policies & strategies
· Identifying current developments in counterfeits & ways to overcome threats
· Discovering successful business models - Opportunities & Challenges
· Identify main challenges and methods to improve Global Security
· International partnerships and EU & U.S. regulations to combat counterfeit medicines
· Practical Tips - Strategies for securing the supply chains of the 21st century - authentication, digital serialization, track and trace technologies and government enforcement
· Best Practices on risk based approach to predict & prevent counterfeiting
· Protect your products - Learn how to use the right packaging identification systems effectively
· Discuss the impact of parallel trade and re-imports on counterfeiting medicines
· Effective drug packaging design and technologies enhancing product efficiency, patient and health personnel security, compliance, ease of use
· Establish robust pharmaceutical anti-counterfeiting and brand protection strategy to protect product and brand revenue
· Involve the latest cutting edge serialisation & track & trace technologies for anti-counterfeiting
· Include anti-counterfeiting in your business plan in order to secure product and supply chain safety in your company
· How the FBI is currently addressing intellectual property crime and partnering with U.S. government agencies

Key Speakers:-

· Ed Wheatley, Regional Investigations Director EMEA, Global Security, AstraZeneca
· Wendy Greenall, Counterfeit Medicines Laboratory Manager – EMEA, Pfizer
· Tomasz Dzitko, CEO, Delfarma
· Ulrike Kreysa, Vice-President Healthcare, GS1 Global Office
· Monika Derecque-Pois, Director General, European Association of Pharmaceutical Full-Line Wholesalers (GIRP)
· Mustafa A. Zaman, Senior Consultant – Integrated Product Development (IPD), Parexel
· Jim Thomson, Chair, European Alliance for Access to Safe Medicines (EAASM)
· Mark Davison, CEO, Blue Sphere Health
· Olgun Yenersoy,
 CEO, ADVANCO
· Tanvi Goel, Global Serialization Manager, Mylan Pharmaceuticals-(EGA representative)
· Neil Lawrence, AIDC Programme Lead – Department of Health, NHS
· Maarten Van Baelen, Medical Affairs Manager, EGA (European Generic Medicines Association)
· Taha Yayci, Chief Executive Officer, TechNarts
· Lisa Lovell, Managing Director & Anti-Counterfeiting, Brand Enforcement
· Marietta Ulrich-Horn, General Manager, Securikett